Skip to content

BIONOVATE TECHNOLOGIES CORP.

CIK 0001575420

← back to feed
Revenue (TTM)
$0
Q1 Nov 2021
Net Income (TTM)
−$108.61K
+12.7% YoY Q1 Nov 2021
EPS Diluted (TTM)
—
Q1 Nov 2021
Gross Margin
—
Q1 Nov 2021
Operating Margin
—
Q1 Nov 2021
Net Margin
—
Q1 Nov 2021
Free Cash Flow (TTM)
—
Q1 Nov 2021
Cash
$0
Q1 Nov 2021
Total Debt
$0
Q1 Nov 2021
Shares Outstanding
7.75M sh
Q1 Nov 2021

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings